William Blair Issues Pessimistic Forecast for SLP Earnings

Simulations Plus, Inc. (NASDAQ:SLP - Free Report) - Analysts at William Blair dropped their Q2 2025 earnings per share (EPS) estimates for Simulations Plus in a research note issued to investors on Wednesday, January 8th. William Blair analyst M. Smock now expects that the technology company will earn $0.22 per share for the quarter, down from their prior forecast of $0.27. William Blair has a "Outperform" rating on the stock. The consensus estimate for Simulations Plus' current full-year earnings is $1.10 per share. William Blair also issued estimates for Simulations Plus' Q4 2025 earnings at $0.35 EPS, FY2025 earnings at $1.09 EPS, Q1 2026 earnings at $0.17 EPS, Q2 2026 earnings at $0.32 EPS, Q4 2026 earnings at $0.43 EPS and FY2026 earnings at $1.35 EPS.

Simulations Plus (NASDAQ:SLP - Get Free Report) last announced its quarterly earnings results on Wednesday, October 23rd. The technology company reported $0.06 earnings per share for the quarter, topping the consensus estimate of $0.04 by $0.02. Simulations Plus had a net margin of 14.15% and a return on equity of 6.16%. The company had revenue of $18.70 million for the quarter, compared to analysts' expectations of $19.73 million. During the same quarter in the previous year, the business posted $0.18 earnings per share. Simulations Plus's quarterly revenue was up 19.9% on a year-over-year basis.

SLP has been the topic of a number of other reports. Stephens assumed coverage on Simulations Plus in a research report on Friday, November 15th. They set an "overweight" rating and a $39.00 price objective on the stock. BTIG Research decreased their price target on Simulations Plus from $60.00 to $50.00 and set a "buy" rating on the stock in a report on Thursday, October 24th. KeyCorp dropped their price objective on shares of Simulations Plus from $40.00 to $35.00 and set an "overweight" rating for the company in a research note on Wednesday. Finally, StockNews.com downgraded shares of Simulations Plus from a "hold" rating to a "sell" rating in a research note on Monday, November 4th. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating, five have issued a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $49.00.

Simulations Plus Price Performance

Shares of NASDAQ SLP traded up $0.04 during mid-day trading on Friday, hitting $28.25. 421,364 shares of the company's stock traded hands, compared to its average volume of 539,644. The company has a market capitalization of $567.40 million, a P/E ratio of 57.65 and a beta of 0.80. Simulations Plus has a 1 year low of $24.00 and a 1 year high of $51.22. The company's 50-day moving average is $29.81 and its two-hundred day moving average is $33.96.

Insiders Place Their Bets

In related news, Director Walter S. Woltosz sold 20,000 shares of the stock in a transaction that occurred on Monday, December 2nd. The stock was sold at an average price of $31.76, for a total value of $635,200.00. Following the transaction, the director now owns 3,442,584 shares of the company's stock, valued at $109,336,467.84. This represents a 0.58 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 19.40% of the company's stock.

Institutional Trading of Simulations Plus

A number of hedge funds have recently added to or reduced their stakes in the business. First Horizon Advisors Inc. boosted its position in Simulations Plus by 82.6% during the third quarter. First Horizon Advisors Inc. now owns 818 shares of the technology company's stock valued at $26,000 after purchasing an additional 370 shares in the last quarter. nVerses Capital LLC boosted its holdings in shares of Simulations Plus by 1,100.0% in the 3rd quarter. nVerses Capital LLC now owns 1,200 shares of the technology company's stock valued at $38,000 after buying an additional 1,100 shares in the last quarter. Quantbot Technologies LP purchased a new position in shares of Simulations Plus in the 3rd quarter worth approximately $59,000. US Bancorp DE raised its stake in shares of Simulations Plus by 37.0% during the 3rd quarter. US Bancorp DE now owns 4,974 shares of the technology company's stock worth $159,000 after acquiring an additional 1,343 shares in the last quarter. Finally, Los Angeles Capital Management LLC purchased a new stake in Simulations Plus during the second quarter valued at approximately $206,000. 78.08% of the stock is owned by hedge funds and other institutional investors.

About Simulations Plus

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.